Invest in intelligence that delivers

Contact

Spherix Market Expertise

Our team of experts and physician
community give you a competitive edge.

Partner with an intelligence team
hyper-focused on your specialty.

Select a speciality to learn more.

Dermatology
Gastroenterology
Rheumatology
Nephrology
Neurology
Ophthalmology
Hematology
Visit our Thought Leadership page to access some of our latest market insights

See the market from the prescribers’ point of view.

Our physician community includes direct relationships with our curated physician network and leading KOLs, who keep us closely connected with the specific challenges of specialty markets.

Vetted Practicing Physicians

Key Opinion Leaders

Professional Organizations

3,300+ members in the Spherix US Physician Community

Our therapeutic experts are always just a click or call away...

  • Plugged into the ever-evolving landscape
  • Ready to provide an unbiased view of the landscape
  • Insightfully answer real-time questions
  • Highlight opportunities 
  • Identify disruptors
Contact Us
“Spherix's Dynamix studies provide us invaluable insights into the physician-patient exchange that guides both our patient-facing programs and our interactions with pharma partners. Their survey reports highlight needs that cannot be assessed by EMR data alone. They also reveal information and resources that patients are not receiving, gaps in support that we can fill. These reports are a glimpse into the patient exam room that we can't get anywhere else.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
"Spherix is unparalleled in their timely and accurate market snapshots with comprehensive feedback on physicians’ impressions, use patterns and projected use of key drugs across the therapeutic categories covered. They are my go-to source when I want insights as to how to model a launch, a competitive dynamic or understand awareness around pipeline agents.”
Senior Biotech Analyst at a Leading Investment Bank
"Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Sign up for alerts, market insights and exclusive content in your inbox.
Subscribe
Linkedin

Download our publication plan

or

Visit our portal for the searchable format

©2025 Spherix. All Rights Reserved.

Site Map

Dermatology

Expertise

7

dedicated team members

10

years of
continuous tracking

56

studies published annually

Indications

  • Alopecia Areata (AA)
  • Asthma
  • Atopic Dermatitis (AD)
  • Chronic Spontaneous Urticaria
  • Hidradenitis Suppurativa (HS)
  • Plaque Psoriasis (PsO)
  • Prurigo Nodularis (PN)
  • Vitiligo
See all Dermatology publications in our portal

Team Lead

Linkedin Envelope

Jim Hickey
Franchise Head, Dermatology

Jim has 20+ years’ experience building and leading research teams, pioneering innovative research techniques, and providing insight solutions to pharmaceutical brands. Prior to Spherix, he led the research team at Verilogue from early startup through its acquisition by Publicis Health. Jim has extensive experience across a wide range of therapeutic categories and a particular interest in gastroenterology and inflammatory disease.

Gastroenterology

Expertise

6

dedicated team members

10

years of
continuous tracking

54

studies published annually

Indications

  • Celiac Disease
  • Celiac Disease
  • Crohn’s Disease
  • Eosinophilic Esophagitis (EoE)
  • Irritable Bowel Syndrome (IBS)
  • Metabolic dysfunction-associated steatotic liver disease/ metabolic dysfunction-associated steatohepatitis (MASLD/MASH) (previously NAFLD/NASH)
  • Primary Biliary Cholangitis
  • Primary Sclerosing Cholangitis
  • Ulcerative Colitis
See all Gastroenterology publications in our portal

Team Lead

Linkedin Envelope

Jim Hickey
Franchise Head, Gastroenterology

Jim has 20+ years’ experience building and leading research teams, pioneering innovative research techniques, and providing insight solutions to pharmaceutical brands. Prior to Spherix, he led the research team at Verilogue from early startup through its acquisition by Publicis Health. Jim has extensive experience across a wide range of therapeutic categories and a particular interest in gastroenterology and inflammatory disease.

Rheumatology

Expertise

6

dedicated team members

10

years of
continuous tracking

37

studies published annually

Indications

  • Ankylosing Spondylitis and Non-Radiographic Axial Spondylitis (AS and nr-axSpA)
  • Cutaneous Lupus Erythematosus (CLE)
  • Idiopathic Inflammatory Myopathy (IIM)
  • Interstitial Lung Disease (ILD)
  • Giant Cell Arteritis (GCA)
  • Lupus Nephritis (LN)
  • Polymyalgia Rheumatica (PMR)
  • Psoriatic Arthritis (PsA)
  • Rheumatoid Arthritis 
  • Sjögren’s Syndrome (SjS)
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis (SSc)
See all Rheumatology publications in our portal

Team Lead

Linkedin Envelope

Lynn Price
Franchise Head, Rheumatology

Lynn has over eight years at Spherix, leading strategic initiatives and insights development. She previously directed research analytics at Decision Resources Group and managed immunology research at BioTrends, with extensive experience in data analysis and client relations in the biopharmaceutical sector.

Nephrology

Expertise

6

dedicated team members

10

years of
continuous tracking

43

studies published annually

Indications

  • Alport Syndrome
  • Chronic Kidney Disease (CKD), Non-Dialysis
  • Complement 3 Glomerulopathy (C3G)
  • Diabetic Kidney Disease (DKD)
  • Dialysis
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Hyperkalemia
  • Hyperphosphatemia
  • IgA Nephropathy (IgAN)
  • Membranous Nephropathy
  • Polycystic Kidney Disease (PKD)
  • Renal Anemia
  • Secondary Hyperparathyroidism (SHPT)
See all Nephrology publications in our portal

Team Lead

Linkedin Envelope
Meghan Weiss 
Franchise Head, Nephrology
Meghan joined Spherix in 2020. Prior to Spherix, she managed custom market research projects across a broad range of industries and developed expertise with complex research methodologies. She holds an MBA with a focus in Health Sector Management from Pennsylvania State University.

Neurology

Expertise

7

dedicated team members

10

years of
continuous tracking

35

studies published annually

Indications

  • Alzheimer’s Disease 
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Epilepsy
  • Huntington’s Disease (HD)
  • Myasthenia Gravis (gMG)
  • Migraine
  • Multiple Sclerosis (MS)
  • Parkinson’s Disease
See all Neurology publications in our portal

Team Lead

Linkedin Envelope

Bob Shewbrooks

Franchise Head, Neurology

Bob has over 25 years of industry experience, having held roles at Wyeth (Pfizer), Otsuka, and Sumitomo, supporting business units and brands. He brings significant experience on the supplier side in consulting, as well as primary and syndicated market research, driving growth and innovation across portfolios.

Ophthalmology

Expertise

8

dedicated team members

3

years of
continuous tracking

19

studies published annually

Indications

  • Age-Related Macular Degeneration
  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy (DR)
  • Geographic Atrophy (GA)
  • Gene Therapies in Retinal Disorders
  • Glaucoma
  • Thyroid Eye Disease
See all Ophthalmology publications in our portal

Team Lead

Linkedin Envelope

Bob Shewbrooks

Franchise Head, Ophthalmology

Bob has over 25 years of industry experience, having held roles at Wyeth (Pfizer), Otsuka, and Sumitomo, supporting business units and brands. He brings significant experience on the supplier side in consulting, as well as primary and syndicated market research, driving growth and innovation across portfolios.

Hematology

NEW in 2024!

3

dedicated team members

9

years of
continuous tracking

34

studies published annually

Indications

  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Autoimmune Hemolytic Anemia (w-AIHA and CAD)
  • Cold Agglutinin Disease (CAD)
  • Graft vs. Host Disease (GvHD)
  • Hemophilia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Sickle Cell Disease (SCD)
  • Thalassemia
  • Thrombocytopenia (Including ITP and TTP)
See all Hematology publications in our portal

Team Lead

Linkedin Envelope

Tucker Hurtado

Franchise Head, Hematology

Tucker has been conducting and leading research for biopharmaceutical companies for more than 15 years. In her previous roles at EVERSANA and Health Strategies Group she led research in brand access and specialty services across more than 30 indications. Her expertise lies in driving brand growth and delivering strategic market insights.

Sign up for alerts, market insights and exclusive content in your inbox.